Close Menu
Home » Illumina Ventures, Arch Venture Partners Invest in Luna DNA

Illumina Ventures, Arch Venture Partners Invest in Luna DNA

May 08, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Genomic and medical research startup Luna DNA, which offers a custom cryptocurrency to reward individuals for sharing their biological and medical information, said today that Illumina Ventures and Arch Venture Partners have become investors in the firm, leading a new round of funding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Viral Genomes Back in Time

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

To Give a Microbiome?

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The End of the Cave Bears

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

PLOS Papers Tackle Trypanosomiasis Susceptibility, Diabetes Modulators, More

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.

What's Popular?

In Business News

  1. Federal Appeals Court Invalidates Second Enzo Biochem Patent in Three Months

  2. Genomind, NeuroFlow Collaborate to Provide Genetic Testing-Based Mental Health Services

  3. Court Tacks On $10M to 10x Genomics Infringement Penalty

  4. Canaccord Genuity, SVB Leerink Initiate Coverage of Castle Biosciences

  5. Myriad Genetics Stock Plummets on Lower-Than-Expected Q4 Revenues, FDA Interactions on GeneSight

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.